ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 85 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $669 | -99.9% | 1,803,858 | 0.0% | 0.04% | -2.6% |
Q3 2022 | $902,000 | -14.4% | 1,803,858 | 0.0% | 0.04% | -32.1% |
Q2 2022 | $1,054,000 | -17.9% | 1,803,858 | 0.0% | 0.06% | +3.7% |
Q1 2022 | $1,284,000 | -46.1% | 1,803,858 | 0.0% | 0.05% | -16.9% |
Q4 2021 | $2,381,000 | -42.6% | 1,803,858 | 0.0% | 0.06% | -30.1% |
Q3 2021 | $4,149,000 | -47.6% | 1,803,858 | 0.0% | 0.09% | -42.2% |
Q2 2021 | $7,919,000 | -39.5% | 1,803,858 | 0.0% | 0.16% | -30.3% |
Q1 2021 | $13,096,000 | +762.7% | 1,803,858 | +413.2% | 0.23% | +600.0% |
Q4 2020 | $1,518,000 | +5.1% | 351,500 | 0.0% | 0.03% | -5.7% |
Q3 2020 | $1,445,000 | -34.9% | 351,500 | -5.0% | 0.04% | -43.5% |
Q2 2020 | $2,220,000 | -26.3% | 370,000 | -7.5% | 0.06% | -51.2% |
Q1 2020 | $3,012,000 | -37.4% | 400,000 | +14.3% | 0.13% | -31.7% |
Q4 2019 | $4,813,000 | +15.8% | 350,000 | 0.0% | 0.19% | +11.4% |
Q3 2019 | $4,158,000 | -15.1% | 350,000 | 0.0% | 0.17% | -15.7% |
Q2 2019 | $4,897,000 | – | 350,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |